What is he best known for?
The fields of study he is best known for:
His main research concerns Biochemistry, Microbiology, Mycobacterium tuberculosis, Mycobacterium and Phosphorylation.
His Biochemistry study frequently draws connections to adjacent fields such as Mycolic acid.
His Microbiology research includes elements of Biofilm, Immune system, Immunology, Lipomannan and Mycobacterium chelonae.
His Mycobacterium tuberculosis study incorporates themes from Antibiotics and Isoniazid.
Many of his research projects under Mycobacterium are closely connected to Cefoxitin with Cefoxitin, tying the diverse disciplines of science together.
His Phosphorylation study integrates concerns from other disciplines, such as Transcription factor and Kinase.
His most cited work include:
- Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. (358 citations)
- Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. (348 citations)
- GroEL1: A Dedicated Chaperone Involved in Mycolic Acid Biosynthesis during Biofilm Formation in Mycobacteria (302 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Microbiology, Mycobacterium tuberculosis, Biochemistry, Mycobacterium abscessus and Mycobacterium.
His study looks at the relationship between Microbiology and topics such as Mycobacterium marinum, which overlap with Glycolipid.
His Mycobacterium tuberculosis research is multidisciplinary, relying on both In vitro, Stereochemistry, Drug resistance and Isoniazid.
His Mycobacterium smegmatis research extends to the thematically linked field of Biochemistry.
His Mycobacterium abscessus research includes themes of Innate immune system, Cystic fibrosis and Immunology, Pathogenesis.
As a part of the same scientific family, he mostly works in the field of Mycolic acid, focusing on Cell envelope and, on occasion, Cell wall.
He most often published in these fields:
- Microbiology (69.61%)
- Mycobacterium tuberculosis (62.50%)
- Biochemistry (59.31%)
What were the highlights of his more recent work (between 2018-2021)?
- Mycobacterium abscessus (37.75%)
- Microbiology (69.61%)
- Mycobacterium tuberculosis (62.50%)
In recent papers he was focusing on the following fields of study:
Laurent Kremer mainly focuses on Mycobacterium abscessus, Microbiology, Mycobacterium tuberculosis, Biochemistry and Antibiotics.
Laurent Kremer has included themes like Innate immune system, In vitro and Virulence in his Mycobacterium abscessus study.
His Microbiology research is multidisciplinary, incorporating perspectives in Cystic fibrosis, Mutant, Nontuberculous mycobacteria, Macrophage and Drug.
His biological study spans a wide range of topics, including Mode of action, Biosynthesis and Isoniazid.
His study in Enzyme, Cell wall, Cytoplasm and Arabinogalactan falls within the category of Biochemistry.
His work in Mycobacterium covers topics such as Drug resistance which are related to areas like Biological activity, Drug development and Structure–activity relationship.
Between 2018 and 2021, his most popular works were:
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. (53 citations)
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. (53 citations)
- CFTR Protects against Mycobacterium abscessus Infection by Fine-Tuning Host Oxidative Defenses (19 citations)
In his most recent research, the most cited papers focused on:
Microbiology, Mycobacterium abscessus, Mycobacterium tuberculosis, Mycolic acid and In vitro are his primary areas of study.
Laurent Kremer has researched Microbiology in several fields, including Phenotype, Cystic fibrosis and Mutant.
His research in Mycobacterium abscessus intersects with topics in Bedaquiline, Cyclophostin, Drug resistance and Virulence.
His Drug resistance research focuses on Mycobacterium and how it connects with Structure–activity relationship, Biological activity, EXTENSIVE DRUG RESISTANCE and Drug development.
He interconnects Mode of action, Sputum and Virology in the investigation of issues within Mycobacterium tuberculosis.
His study focuses on the intersection of In vitro and fields such as Benzimidazole with connections in the field of Nontuberculous mycobacteria, Trehalose dimycolate, Biochemistry and SQ109.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
